ISN 9.09% 6.0¢ isonea limited

note to long term holders, page-21

  1. 7,746 Posts.
    20x seems over the top. How much growth is their in an app? To have any chance of decent revenue, they will definately need to go the monthly billing option and not a one off fee. They have never been clear on how they plan billing gen2. If it's one off then they will struggle to be profitable let alone decent sp. If it's monthly then it will become a harder sell because it's an added expense everymonth that strugglers won't like. Almost lose-lose situation.

    They will re-invent the Wheezometer, make it smaller and hopefully cheaper. But the original never sold in large qty. So their doesn't seem much value in some of their patents like holter monitor.
 
watchlist Created with Sketch. Add ISN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.